ASP3772

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline, Affinivax, Inc.

Conditions

Healthy VolunteersPneumococcal DiseasePneumonia, Bacterial

Phase 1

A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine

CompletedNCT03803202

GlaxoSmithKlineHealthy Volunteers, Pneumococcal Disease, Pneumonia, Bacterial

Start: 2019-01-24End: 2020-09-28Updated: 2023-12-21

A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

CompletedNCT04525599

Affinivax, Inc.Healthy Volunteers, Pneumococcal Disease

Start: 2020-09-22End: 2022-04-06Updated: 2022-06-06

Related Papers

Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years

Vaccine2022-06-0967 citations